Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes    » A1c    » Adolescents    » Awareness    » Cause    » Children    » Complications    » Control    » Costs    » Cure    » Diagnosis    » Drugs    » Elderly    » Gestational    » Hypoglycemia    » Impaired Fasting Glucose    » Impaired Glucose Tolerance    » Inflammation    » Insulin Resistance    » Insulin Sensitivity    » Men    » Metabolic Syndrome    » Minorities    » Obesity    » Organs    » Other Diseases    » Pancreas    » Pre-Diabetes    » Prevention    » Research    » Risk Factors    » Screening    » Statistics    » Stress    » Syndrome X    » Testing    » Treatments    » Type 1    » Type 2    » Warning Signs    » Women Body Care Children Complications Defeat Diabetes Foundation Drugs Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

About Diabetes » Insulin Sensitivity

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Sugar Substitutes Increase Release of GLP-1 Posted: Sunday, December 27, 2009

Combining artificial sweeteners with the real thing boosts the stomach's secretion of a hormone that makes people feel full and helps control blood sugar, new research shows.

First Pancreas Removal and Islet Cell Transplantation Performed Posted: Sunday, December 20, 2009

A 21-year old airman severely wounded in Afghanistan is recovering at Walter Reed Army Medical Center, Bethesda, MD, after several surgeries and an unprecedented transplant.

Approved Drug Slows Type 1 Diabetes Posted: Sunday, December 20, 2009

The drug rituximab already used to treat autoimmune disorders may also slow the destruction of insulin-producing cells in patients with insulin-dependent (Type 1) diabetes.

Novo Nordisk Begins Trial with Oral Insulin Posted: Sunday, December 20, 2009

Novo Nordisk started the first human tests on an experimental insulin pill, NN1952, joining companies seeking to develop an alternative to daily injections for diabetes patients who need the hormone to control their disease.

Exenatide Once Weekly DURATION-5 Study Results Announced Posted: Sunday, December 20, 2009

Eli Lilly and Company, and Amylin announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with Type 2 diabetes.

One-Hour Glucose Levels a Marker for Heart Disease Posted: Sunday, December 20, 2009

Elevated 1-hour plasma glucose (1hPG) levels in persons without overt diabetes (DM) may be a marker for cardiovascular risk, according to the results of a study.

Update on Generex Oral-lyn Posted: Sunday, December 13, 2009

An independent review of clinical trials of Generex Oral-lyn(TM) shows that the oral insulin spray has a faster onset of action and shorter duration of action than insulin delivered subcutaneously.

Self Monitoring Blood Glucose Benefits All Patients with Diabetes Posted: Sunday, December 06, 2009

Experts underline benefits of SMBG for all types of diabetes treatment plans.

BARI 2D Study Favors Medication over Bypass Surgery for Diabetes Patients Posted: Monday, November 30, 2009

Many patients with diabetes should forego angioplasties for heart disease and just take medicine instead, according to a new National Institutes of Health study led by Stanford University School of Medicine researcher Mark Hlatky, MD.

Discovery of Insulin Production Mechanism Can Lead to Better Treatment for Diabetes Posted: Monday, November 23, 2009

How a specific gene within the pancreas affects secretion of insulin has been discovered by researchers from the Hebrew University of Jerusalem.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.